Novel depsipeptides, namedchondramides were produced at levels up to 4.3 mg/liter by several myxobacteria of the genus Chondromyces. The compounds are structurally closely related to jaspamide/jasplakinolide from marine sponges of the genus Jaspis. Initially the chondramides were detected in acetone extracts of the biomass of Chondromycescrocatus, strain Cmc2. So far, four structural variants could be characterized, the chondramides A~D. They inhibited the growth of a few yeasts and showed high cytostatic activity against cultivated human and animal cells.
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The introduction of the more fastidious and unusual genus Chondromyces into our continuous antibiotic screening of myxobacteria resulted in a number of interesting novel activities. Besides the recently described antifungal crocacin1} we detected in several culture extracts of the species C. crocatus a second compound showing weak activity against some yeasts and high cytotoxicity against cultivated mammalian cells. Structure elucidation revealed the activity to be due to a mixture of new depsipeptides, which we named chondramides. In their structures the so far characterized chondramides A~D ( Fig.  1) show a remarkable similarity to jaspamide2), or jasplakinolide3 '4) , isolated from the soft bodied marine sponge Jaspis johnstoni (order Astrophorida, family Jaspidae). In this article we describe the production, isolation, and some of the physico-chemical and biological properties of chondramides A~D. The structure elucidation will be published elsewhere5).
Characterization of the Producing Organisms and Culture Conditions Initially the producing organism was C. crocatus, strain Cmc2, isolated at the GBFin 1985 from a soil sample collected on Madeira. Later on the chondramides were found to be produced by all strains of the species C. crocatus tested by us, viz. Cmcl, Cmc3, Cmc4, Cmc5, Cmc6 and Cmc7. On a larger scale, the chondramides were mostly produced with strain Cmc5, which was isolated at the GBFin 1988 from a soil sample collected in Brazil. After the organisms had been adapted to growth in liquid media as described for the production of crocacin1}, they were grown in media containing and trace element solutions, 50niM HEPES,pH.7.0. Batch cultures of 100ml or 400ml in 250-ml or 1,000-ml Erlenmeyer flasks, respectively, were incubated at 30°C on a gyratory shaker at 160rpm for 3^5 days. As mentioned previously for strain Cm c31}, a second bacterium was also observed in cultures of Cmc2 and several other C. crocatus strains. The characterization of the companion bacterium has been described6). Production
The total yields of the chondramides produced by the different C crocatus strains were determined by HPLC The UV spectrum of chondramide A in methanol was recorded with a Hitachi U 3200 spectrophotometer (Fig. 3) . It had maxima at 2max (loge) 222nm (4.56), 279nm (3.79), 290nm (3.67). The spectra of chondramides B, C and D showed the same maxima. The IR spectrum of chondramide A in KBr, measured with a Nicolet 20 DXBFT-IR spectrometer, is given in Fig. 4 .
Biological Activity The antimicrobial activity of the chondramides A~D was determined by agar diffusion tests and is presented in Table 2 . The compounds were completely inactive against Gram-positive and Gram-negative bacteria, inhibited the growth of several yeasts, but not that of filamentous fungi. The MIC for Candida albicans determined by a serial dilution assay was 25/xg/ml for chondramides B and D, and 50 jUg/ml for chondramides A and C. The chondramides proved to be highly effective in mammalian cell cultures (Table 3) . Concentrationdependent growth inhibition of different cell lines was determined 5 days after the addition of the various chondramides by an MTTassay, which measures the shows the dose response curves of the chondramides A~D with the continuously growing KB-3-1 cell line (DSM ACC158), which was established from a primary cervical carcinoma. The course of the inhibition was similar for the different chondramides, the IC50 values ranged from 2 to 7 ng/ml. Fig. 6 shows the growth kinetics ofK-562 (ATCC CCL 243) leukemia cells in the presence and absence of chondramide A. The cells were cultivated Table 2 . Antimicrobial spectrum of the chondramides A~D. 
Discussion
After crocacin, the chondramides are the second group of biologically active substances isolated from strains of the myxobacterium, C. crocatus. We detected the chondramides in varying amounts in seven C. crocatus strains tested, which suggests that the chondramides, like crocacin, are widely distributed in this species. Furthermore, the strains of this species belong to those myxobacteria, which synthesize two or more chemically unrelated secondary metabolites with different mechanisms of action8). The antimicrobial and cytostatic activity of the chondramides is similar to that of the structurally related japamides/jasplakinolides2~4). It is most interesting, that the chondramides also show activity against the KB-V1cell line, which is resistant against the cytostatic drug, vinblastin. First investigations on the mechanism of action suggest that, like jasplakinolide9), the chondramides interfere with actin polymerisation.
So far no other myxobacterial species has been found to produce chondramides. Thus it is even more remarkable that chemically closely related but otherwise unique compounds, viz., the chondramides and jaspamide2'3), occur in phylogenetically so distant organisms as a myxobacterium and a marine sponge (Jaspis). If one would assume that the sponge harvests jaspamide with planktonic bacterial feed, still the problem remains that no halotolerant myxobacteria are known. While the most of our C. crocatus strains only grow in the presence of a (taxonomically identical6)) companion bacterium, and NOV. 1995 thus have to be fermented as mixed cultures, there also are strains which grow as pure cultures, e.g. Cmc5. As this strain produces the same pattern of secondary metabolites as the symbiotic cultures, biosynthesis of all those substances must be performed exclusively by the myxobacterium.
